NCT07397442 2026-02-11
Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer
Beijing Friendship Hospital
Phase 2 Not yet recruiting
Clinical Trials
16 trialsNCT07333287 2026-01-12
A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.
Shandong Provincial Hospital
Phase 2 Not yet recruiting
NCT07259473 2026-01-07
Pre-CATALIS
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT07293247 2025-12-22
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Alliance for Clinical Trials in Oncology
Phase 2 Not yet recruiting
NCT07297030 2025-12-22
SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT07258147 2025-12-02
Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases
Sichuan University
Phase 2 Not yet recruiting
NCT07254858 2025-11-28
CISN-L
First Affiliated Hospital of Wenzhou Medical University
Phase 2 Not yet recruiting
NCT07231575 2025-11-18
Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT07118566 2025-08-12
Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases
China Medical University, China
Phase 2 Not yet recruiting
NCT06908668 2025-04-03
Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06691594 2025-02-20
Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06599827 2024-09-19
iMHRT-LARC
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT06009029 2023-08-24
SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)
Peking University Third Hospital
Phase 2 Not yet recruiting
NCT05794750 2023-04-06
AK104-IIT-13
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT05791136 2023-03-30
TREE
The Central Hospital of Lishui City
Phase 2 Not yet recruiting
NCT05359393 2022-11-14
Miracle-1
Fudan University
Phase 2 Not yet recruiting